|
Clerk of the House of Representatives Legislative Resource Center 135 Cannon Building Washington, DC 20515 http://lobbyingdisclosure.house.gov |
Secretary of the Senate Office of Public Records 232 Hart Building Washington, DC 20510 http://www.senate.gov/lobby |
LOBBYING REGISTRATION
Lobbying Disclosure Act of 1995 (Section 4)
| 1. Effective Date of Registration | 1/1/2020 |
||||
| 2. House Identification | 38067 |
Senate Identification | 304736 |
||
REGISTRANT Organization/Lobbying Firm Self Employed Individual
| 3. Registrant | Organization | Tarplin, Downs & Young, LLC |
||||
| Address | 1212 New York Avenue, NW |
Address2 | Suite 750 |
| City | Washington |
State | DC |
Zip | 20005 |
Country | USA |
4. Principal place of business (if different than line 3)
| City |
|
State |
|
Zip |
|
Country |
|
| 5. Contact name and telephone number | International Number |
| Contact | Ms. Jennifer B. Young |
Telephone | 2028984733 |
jyoung@tdyllc.com |
CLIENT A Lobbying Firm is required to file a separate registration for each client. Organizations employing in-house lobbyists should check the box labeled “Self” and proceed to line 10. Self
| 7. Client name | Novo Nordisk Inc. |
| Address | 920 Massachusetts Avenue., NW, Suite 500 |
| City | Washington |
State | DC |
Zip | 20001 |
Country | USA |
| City | Plainsboro |
State | NJ |
Zip | 08536 |
Country | USA |
LOBBYISTS
10. Name of each individual who has acted or is expected to act as a lobbyist for the client identified on line 7. If any person listed in this section has served as a “covered executive branch official” or “covered legislative branch official” within twenty years of first acting as a lobbyist for the client, state the executive and/or legislative position(s) in which the person served.
| Name | Covered Official Position (if applicable) | ||
First |
Last |
Suffix |
|
| Raissa | Downs | Ms. | Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Staff Dir., Sub. Cmte. on Employment, Sen. HELP Cmte. |
| Jennifer | Young | Ms. | Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff, Sen. Cmte. on Finance |
| Michelle | Easton | Ms. | Chief Health Counsel, Sen. Cmte. on Finance; Staff Dir., Senate Aging Cmte.; Leg. Asst., Congressman Billy Tauzin |
| Elizabeth | Murray | Ms. | Senior Policy Advisor, Democratic Whip Steny Hoyer; Legislative Asst. for Rep. Mike Thompson, Rep. Bob Matsui, and Senator Bob Graham |
| Charlotte | Ivancic | Ms. | Leg. Counsel, Sen. Jim DeMint; Health Counsel, Maj. Leader Bill Frist; Counsel and Budget Analyst, House Budget Cmte.; Asst. to the Speaker for Policy, Speaker John Boehner |
LOBBYING ISSUES
11. General lobbying issue areas (Select all applicable codes).
MMM |
HCR |
PHA |
BUD |
TAX |
DEF |
CPT |
GOV |
|
12. Specific lobbying issues (current and anticipated)
Issues related to diabetes and obesity
AFFILIATED ORGANIZATIONS
13. Is there an entity other than the client that contributes more than $5,000 to the lobbying activities of the registrant in a quarterly period and either participates in and/or in whole or in major part supervises or controls the registrant’s lobbying activities?
| No --> Go to line 14. | Yes --> Complete the rest of this section for each entity matching the criteria above, then proceed to line 14. |
| Internet Address: |
|
| Name | Address | Principal Place of Business | ||||||||
| Street | ||||||||||
|
||||||||||
|
|
|
||||||||
|
|
|||||||||
|
|
|
||||||||
|
|
|||||||||
|
|
|
||||||||
|
|
FOREIGN ENTITIES
14. Is there any foreign entity
a) holds at least 20% equitable ownership in the client or any organization identified on line 13; or
b) directly or indirectly, in whole or in major part, plans, supervises, controls, directs, finances or subsidizes activities of the client or any organization identified on line 13; or
c) is an affiliate of the client or any organization identified on line 13 and has a direct interest in the outcome of the lobbying activity?
| No --> Sign and date the registration. | Yes --> Complete the rest of this section for each entity matching the criteria above, then sign the registration. |
| Address | Ownership | |||||
| Name | Street | Principal place of business | Amount of contribution | |||
|
(city and state or country) | for lobbying activities | ||||
Tuborg Havnevej 19 2900 |
|
|||||||||||
Registrant is a wholly-owned subsidiary of Novo Nordisk US which is wholly-owned by Novo Nordisk A/S. |
|
|
0.00 |
100 |
% | |||||||
Tuborg Havnevej 19 2900 |
|
|||||||||||
Novo A/S (Owns 26.5% of NN A/S) |
|
|
0.00 |
26.5 |
% |
CONVICTIONS DISCLOSURE
15. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Signature | Digitally Signed By: Jennifer B. Young |
Date | 1/31/2020 2:12:07 PM |
10. Supplemental. List any additional lobbyists for this client not listed on page 1, number 10.
| Name | Covered Official Position (if applicable) | Have you been convicted of a crime? | ||
First |
Last |
Suffix |
||
| Pamela | Smith | Ms. | Leg. Dir., Sen. Tom Harkin; Dep. Staff Dir., Senate HELP Cmte; Staff Dir., Senate HELP Cmte; Counselor to the Asst. AG, Civil Div., Dept of Justice; Spec Counsel, Ofc of Leg. Affairs, Dept of Justice; Counsel and LA, Senator Carol Moseley-Braun | |
| Emily | Murry | Ms. | Staff Dir., Sub. Cmte. on Health, W&M Cmte; Sr. Policy Advisor, Majority Leader McCarthy; Policy Advisor, Majority Whip McCarthy; Professional Staff, Republican Study Cmte.; Leg. Aid, Rep. Ken Calvert; Leg. Asst., Rep. Tom Price | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
|
|
|
|
|
|
|
|
|
| Name | Address | Principal Place of Business | ||||||||
| Street | ||||||||||
|
||||||||||
|
|
|
||||||||
|
|
|||||||||
|
|
|
||||||||
|
|
|||||||||
|
|
|
||||||||
|
|
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership | ||||||||||||||
| ||||||||||||||||||
Novo Nordisk Fonden (ultimate parent company) |
|
|
0.00 |
100 % |
||||||||||||||
|
|
|
|
% |
||||||||||||||
|
|
|
|
% |
||||||||||||||